AUSTIN, Texas--(BUSINESS WIRE)--Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, today reported financial results for its third quarter ended September 28, 2025. Financial highlights for the third quarter ended September 28, 2025, compared to the third quarter ended September 29, 2024, include: Net Revenue increased 37.2% to $198.9 million, compared to $145.0 million Gross Margin of 37.7%, compared to 36.9% Net Income of $16.4 mil. ...

FRISCO, TX, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Comstock Resources, Inc. ("Comstock" or the "Company") (NYSE; NYSE Texas: CRK) today reported financial and operating results for the quarter ended September 30, 2025. Highlights of 2025's Third Quarter Higher natural gas prices in the third quarter drove improved financial results in the quarter. Natural gas and oil sales, including realized hedging gains, were $335 million for the quarter.Operating cash flow was $190 million or $0.65 per diluted share.Adjusted ...

"Company†), America's largest producer of trade shows and their associated conferences, content and commerce, today reported financial results for the third quarter ended September 30, 2025. Year-To-Date 2025 Financial Highlights Revenues of $330.7 million, an increase of $38.7 million, or 13.3%, over the prior year period, primarily due to revenues from acquisitions and higher Organic Revenues. Organic Revenues, a n. NEW YORK--(BUSINESS WIRE)--Emerald Holding, Inc. (NYSE: EEX) ("Emerald†or the ...

BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services, today announced financial results for the fiscal third quarter ended September 27, 2025. "CRA continued its run of strong results into the third quarter of fiscal 2025 as revenue increased by 10.8% year over year to $185.9 million,†said Paul Maleh, CRA's President and Chief Executive Officer. "Our performance during the quarter was broad-base. ...

BANNOCKBURN, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights (Year-over-year comparisons unless otherwise noted) Net revenue of $1,435.0 million, up 12.2%Gross profit of $272.9 million, up 6.3%Net income of $51.8 million, down 3. ...

today reported diluted earnings per common share of $1.20 for the third quarter of 2025, compared with $1.06 during the linked quarter and $0.93 during the same period last year. Net income for the third quarter of 2025 was $53.3 million, up 12.0% from the linked quarter and up 32.2% from the same period last year. The return on average common equity for the third quarter of 2025 was 13.59% compared with 12.50% d. HONOLULU--(BUSINESS WIRE)--Bank of Hawai'i Corporation (NYSE: BOH) (the "Company†) ...

顶点软件公告，第三季度营收为1.39亿元，下降9.50%；净利润为5040.37万元，下降3.91%。前三季度 营收为3.85亿元，下降8.53%；净利润为1.03亿元，增长2.02%。 ...

财务表现 - 2025财年第四季度净销售额为9亿7820万美元，同比增长2.7% [1] - 季度营业利润为8430万美元，经调整后为9030万美元 [1] - 季度营业利润率为8.6%，经调整后为9.2% [1] - 季度摊薄后每股收益为1.01美元，上年同期为0.99美元 [1] - 季度经调整后摊薄每股收益为1.09美元 [1]

核心业绩表现 - 公司2025年第三季度净销售额达8.046亿美元，同比增长7.7%，有机增长率为5.0% [2][7] - 第三季度稀释后每股收益为1.92美元，调整后稀释每股收益为1.96美元，高于去年同期的1.85美元 [7] - 公司2025年前九个月净销售额为22.691亿美元，同比增长5.8%，经营现金流为5.037亿美元，增长8.7% [4][19] 业务分部业绩 - 专有产品部门第三季度净销售额为6.475亿美元，增长7.7%，有机增长5.1% [2] - 合同制造产品部门第三季度净销售额为1.571亿美元，增长8.0%，有机增长4.9%，占公司总销售额的20% [3] - 高价值产品组件销售额达3.9亿美元，同比增长16.3%，有机增长13.3%，占公司总销售额的48% [8] 财务指引上调 - 公司将2025年全年净销售额指引上调至30.60亿至30.70亿美元，此前指引为30.40亿至30.60亿美元 [7][9] - 2025年全年调整后稀释每股收益指引上调至7.06至7.11美元，此前指引为6.65至6.85美元 [7][9] - 第四季度净销售额指引为7.90亿至8.00亿美元，预计报告增长5.5%至6.8%，有机增长1.0%至2.3% [10] 现金流与资本管理 - 公司2025年前九个月自由现金流为2.939亿美元，同比大幅增长53.7% [4] - 同期资本支出为2.098亿美元，同比下降22.9% [4] - 公司在前九个月以平均每股242.55美元的价格回购了552,593股股票，总价值1.34亿美元 [5] 产品与市场驱动因素 - 业绩增长主要受GLP-1产品执行力度加强、高价值产品转换以及整体需求环境改善推动 [2] - 合同制造部门增长由肥胖和糖尿病自我注射装置销售增加驱动，但部分被医疗诊断设备销售下降所抵消 [3] - 生物制品市场领域表现强劲，第三季度销售额达3.291亿美元，增长11.0%，有机增长8.3% [25]

-- Favorable Product Mix and Targeted Price Increases Drive Solid Top-Line Growth in Q4 -- -- Efficiency Actions Contributed to Q4 Operating Cash Flow of $181.4 Million -- -- Balance Sheet Strength Fortified as Leverage Ratio Improves -- -- Barletta Continues Share Expansion in U.S. Aluminum Pontoon Segment(1) -- -- Grand Design RV and Newmar Expand Share in Key Motorhome Segments(1) -- -- Company Issues Fiscal 2026 Financial Guidance -- EDEN PRAIRIE, Minn., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Winnebago In ...